# Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy

> **NCT00125697** · — · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 49 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **PROCEDURE:** 3T MRI Scanning

## Key facts

- **NCT ID:** NCT00125697
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125697, "Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00125697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*